Cargando…
Predictors of long-term (≥ 6 months) antipsychotic polypharmacy prescribing in secondary mental healthcare
INTRODUCTION: The predictors of long-term antipsychotic polypharmacy (APP) initiation are poorly understood. Existing research has been hampered by residual confounding, failure to exclude cross-titration, and difficulties in separating the timing of predictors and APP administration. MATERIALS AND...
Autores principales: | Kadra, Giouliana, Stewart, Robert, Shetty, Hitesh, Downs, Johnny, MacCabe, James H., Taylor, David, Hayes, Richard D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Publisher B. V
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922621/ https://www.ncbi.nlm.nih.gov/pubmed/27091655 http://dx.doi.org/10.1016/j.schres.2016.04.010 |
Ejemplares similares
-
Antipsychotic polypharmacy prescribing and risk of hospital readmission
por: Kadra, Giouliana, et al.
Publicado: (2017) -
Predicting parkinsonism side-effects of antipsychotic polypharmacy prescribed in secondary mental healthcare
por: Kadra, Giouliana, et al.
Publicado: (2018) -
Long‐term antipsychotic polypharmacy prescribing in secondary mental health care and the risk of mortality
por: Kadra, G., et al.
Publicado: (2018) -
Extracting antipsychotic polypharmacy data from electronic health records: developing and evaluating a novel process
por: Kadra, Giouliana, et al.
Publicado: (2015) -
Risk of readmission in patients with schizophrenia and schizoaffective disorder newly prescribed clozapine
por: Kesserwani, Jad, et al.
Publicado: (2019)